JPWO2023140350A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2023140350A5
JPWO2023140350A5 JP2023575312A JP2023575312A JPWO2023140350A5 JP WO2023140350 A5 JPWO2023140350 A5 JP WO2023140350A5 JP 2023575312 A JP2023575312 A JP 2023575312A JP 2023575312 A JP2023575312 A JP 2023575312A JP WO2023140350 A5 JPWO2023140350 A5 JP WO2023140350A5
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
organ
composition according
change
fibrosis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023575312A
Other languages
English (en)
Japanese (ja)
Other versions
JPWO2023140350A1 (https=
Publication date
Application filed filed Critical
Priority claimed from PCT/JP2023/001676 external-priority patent/WO2023140350A1/ja
Publication of JPWO2023140350A1 publication Critical patent/JPWO2023140350A1/ja
Publication of JPWO2023140350A5 publication Critical patent/JPWO2023140350A5/ja
Pending legal-status Critical Current

Links

JP2023575312A 2022-01-21 2023-01-20 Pending JPWO2023140350A1 (https=)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2022007849 2022-01-21
PCT/JP2023/001676 WO2023140350A1 (ja) 2022-01-21 2023-01-20 臓器の線維化抑制用医薬組成物

Publications (2)

Publication Number Publication Date
JPWO2023140350A1 JPWO2023140350A1 (https=) 2023-07-27
JPWO2023140350A5 true JPWO2023140350A5 (https=) 2024-11-07

Family

ID=87348421

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023575312A Pending JPWO2023140350A1 (https=) 2022-01-21 2023-01-20

Country Status (4)

Country Link
US (1) US20250170102A1 (https=)
EP (1) EP4467156A4 (https=)
JP (1) JPWO2023140350A1 (https=)
WO (1) WO2023140350A1 (https=)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2708004C (en) * 2006-12-04 2015-12-01 Promedior, Inc. Conjoint therapy for treating fibrotic diseases
CN107405406A (zh) * 2015-03-02 2017-11-28 维科尔药物公司 用于治疗肺纤维化的血管紧张素ii受体激动剂
JPWO2017170434A1 (ja) * 2016-03-28 2019-01-31 インターセプト ファーマシューティカルズ， インコーポレイテッド Ｆｘｒアゴニストとａｒｂの組み合わせ医薬
ES2921257T3 (es) * 2016-06-20 2022-08-22 Daegu Gyeongbuk Medical Innovation Found Nuevo derivado de imidazopiridina, procedimiento para prepararlo y composición farmacéutica que contiene el mismo como ingrediente activo para prevenir o tratar el cáncer
EP3842099A1 (en) * 2019-12-23 2021-06-30 Albert-Ludwigs-Universität Freiburg Use of losartan for the treatment of fibrotic diseases, in particular epidermolysis bullosa

Similar Documents

Publication Publication Date Title
CN1929845B (zh) Pdeⅲ抑制剂在制备用于降低患有心力衰竭的哺乳动物的心脏大小的药物中的用途
CA3083327A1 (en) Combination of a 4-pyrimidinesulfamide derivative with an sglt-2 inhibitor for the treatment of endothelin related diseases
CN101450211A (zh) 复方降压制剂
DK3027183T3 (en) SELECTIVE AT2 RECEPTOR AGONISTS FOR USING CACKSY TREATMENT
JP5968927B2 (ja) 高血圧と代謝症候群の治療に用いられる薬物組成物及びその応用
CA3053991A1 (en) Combinations of a 4-pyrimidinesulfamide derivative with active ingredients for the treatment of endothelin related diseases
US20100273807A1 (en) Use of PDE III Inhibitors for the Treatment of Asymptomatic (Occult) Heart Failure
CN109069507A (zh) 匹莫苯对于患有由二尖瓣疾病所致的无症状心力衰竭的患者中减小心脏尺寸和/或延迟临床症状的发作的用途
JPH11228410A (ja) イミダゾールアンジオテンシン−ｉｉ受容体拮抗薬からなる慢性腎不全治療剤
RU2005128124A (ru) Фармацевтические препараты и их применение для профилактики удара, диабета и/или застойной сердечной недостаточности
CA2532450A1 (en) Chlorthalidone combinations
CO6180425A2 (es) Antagonista del receptor de angiotensina ii para la prevencion o el tratamiento de enfermedades generalizadas en gatos
US20190241545A1 (en) 1,3-Dihydroimidazole-2-Thione Derivatives for Use in the Treatment of Pulmonary Arterial Hypertension and Lung Injury
WO2017006254A1 (en) Drug combination comprising an angiotensin ii receptor antagonist, a neutral endopeptidase inhibitor and a mineralcorticoid receptor antagonist
EP2157089B1 (en) The therapeutic uses of imidazol-5-carboxylic acid derivatives
CN101417132A (zh) 一种含有卡维地洛和血管紧张素ⅱ受体拮抗剂的药物组合物在制备用于治疗肾病的药物中的用途
JPWO2023140350A5 (https=)
CA3009609C (en) Prevention and treatment of heart failure
CN101439039B (zh) 增强剂
CN104324377B (zh) 一种复方降压制剂及其应用
EP1787647A1 (en) Remedy for glomerular diseae
WO2009088006A1 (ja) 併用医薬
JP2002145770A (ja) 心不全の予防又は治療のための医薬組成物
JP4974255B2 (ja) アンジオテンシンｉｉ受容体拮抗剤の配合剤
Mbah Angiotensin II Receptor Antagonists: The Utility of the Therapeutic Agents in Clinical Practice